Question 1

Has Gerard Vockley received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $4,760,952 in general payments to Gerard Vockley across 483 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Gerard Vockley did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Gerard Vockley come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Biomarin Pharmaceutical Inc.	166	$1,799,749
Ultragenyx Pharmaceutical Inc.	143	$1,771,784
AstraZeneca	33	$301,651
Acadia Pharmaceuticals Inc	15	$206,840
Shire North American Group Inc	4	$139,206
PTC Therapeutics, Inc.	40	$125,955
Sanofi	13	$118,622
Amicus Therapeutics, Inc.	11	$84,859
Amgen(2 entities)	27	$83,124
Modernatx, Inc.	14	$67,851
Travere Therapeutics, Inc.	2	$28,836
Radius Health, Inc.	1	$10,000
Sanofi US Services Inc.	1	$9,300
Agios Pharmaceuticals, Inc.	4	$8,347
Ipsen Innovation	1	$1,500
BTG International Inc.	2	$1,500
Tanabe Pharma America, Inc.	3	$1,031
Applied Therapeutics, Inc.	1	$675
Recordati_rare_diseases_inc.	1	$91
Chiesi USA, Inc.	1	$34

Gerard Vockley

Payments from drug & device makers

Who reported the general payments